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Outbreaks of Streptococcus pneumoniae
(antibiotic resistant and nonresistant) have been
reported from child-care centers, nursing homes,
hospitals, military camps, homeless shelters,
and penal institutions (1-6). Simultaneous cases
within households have rarely been reported
(7-11); such cases require common exposure and
transmission, as well as similar likelihood of
disease in the hosts or increased virulence in the
pathogen.
In December 1996 and January 1997, three
married couples with multidrug-resistant
S. pneumoniae (MDRSP) were admitted to
Foothills Medical Centre in Calgary. The couples
were not admitted on the same day. None of the
couples lived with children, although couple C
had daily contact with children. All patients
received appropriate antibiotic therapy after
their culture and antibiotic sensitivity results
were known. We reviewed each patients health
record (Table) and were able to contact two of the
three couples for further information.
S. pneumoniae were identified by standard
methods. MICs were determined by E-Test (AB
Biodisk, Solna, Sweden) and classified as
susceptible (S), intermediate resistant (I), or
fully resistant (R) to each antibiotic, according to
National Committee for Clinical Laboratory
Standards guidelines (12). Serotyping of
S. pneumoniae was performed by the Quellung
reaction technique at the National Centre for
Streptococcus, Edmonton. Electrophoretic fin-
gerprinting of S. pneumoniae was performed by
pulsed-field gel electrophoresis (PFGE) of DNA
digested with Sma1 (BRL, Gaithersburg, MD).
The PFGE patterns were classified as indistin-
guishable, related, or different according to
criteria suggested by Tenover (13).
The diagnosis of S. pneumoniae pneumonia
in couple A was confirmed by positive blood
cultures, chest X-ray lobar pneumonia, and
disease-compatible clinical findings. Patient 1 in
couple A was a health records clerk at Foothills
Medical Centre. Her illness was complicated
soon after admission by empyema, which was
drained; the fluid was S. pneumoniae-negative.
Vertebral osteomyelitis was suspected from
clinical evidence 18 days after admission and was
confirmed by bone scan; no diagnostic culture
was obtained. Osteomyelitis in this patient was
presumably caused by S. pneumoniae. The
initial 7-day course of cefuroxime (to which
S. pneumoniae was resistant) may not have
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Proven or presumptive multidrug-resistant Streptococcus pneumoniae pneumonia
was diagnosed simultaneously in three married couples in Alberta, Canada. The pair of
isolates from each couple had identical antibiotic resistance profiles, serotypes, and
pulsed-field gel electrophoresis patterns. One or more of these cases could have been
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Table. Clinical and laboratory features of three couples with Streptococcus pneumoniae pneumonia
Couple A Couple B Couple C
Feature Patient 1 Patient 2 Patient 1 Patient 2 Patient 1 Patient 2
Age (yrs) 62 61 72 71 39 37
Chronic Hypertension, Gout, 3 Hypertension, COPDc Recurrent Recurrent
conditions diabetes previous MIsa CADb sinusitis sinusitis
Smoker No No Yes Yes Yes Yes
S. pneumoniae No No Unknown Unknown No No
vaccine
Recent None None Unknown Unknown >3 courses in >3 courses in
antibiotics previous year previous year
Others in home None None None None None None
Initial URTId URTId URTId URTId Burn, recent Burn, recent
complaints symptoms, symptoms, symptoms, symptoms, URTId URTId
cough, fever cough, fever cough, fever, cough, fever, symptoms, symptoms,
chest pain chest pain, cough, fever cough, fever
eye discharge
Physical exam Febrile, ­HRe,   Febrile, ­HRe, Febrile, ­HRe, Febrile, ­HRe, Febrile, ­dis- Febrile, ­dis-
­RRf, severe ­RRf, ¯breath ­RRf, ¯breath ­RRf,  ¯breath tress on venti- tress on venti-
distress, sounds sounds, ¯O2 sounds lator, ¯breath lator, ¯breath
¯breath sounds saturation sounds, sounds,
crepitations crepitations
Chest X-ray Right upper Right lower Bibasilar Extensive Day 3  Day 2 
(admission or lobe lobe consolidation right-sided extensive extensive
as noted) consolidation consolidation consolidation bilateral bilateral
consolidation consolidation
Admitting Right lobe Bilateral Pneumonia Lobar Burn Burn
diagnosis pneumonia pneumonia pneumonia
Discharge Right upper Right lower Pneumonia Lobar Burn, Burn,
diagnosis lobe lobe pneumonia complicated complicated
pneumonia pneumonia by pneumonia by pneumonia
fatal sepsis
Complications Empyema, None None None None Died
osteomyelitis
Source of Day 1 - blood Day 1 - blood Day 1 - sputum Day 1 - sputum Day 3 - ETTg Day 2 - BALh
isolate (4+i) (3+i) (4+i) (105 CFU/mLi)
Gram stain Not applicable Not applicable GPC GPC resem- GPC GPC
resembling bling S. pneu- resembling resembling
S. pneumoniaej moniaej, GNBk S. pneumoniaej S. pneumoniaej
Other potential None None None H. influenzae GNBk H. influenzae





  Penicillin 2      R 1.5   I 1.5   R 2      I 1.5    I 1       I
  Cefuroxime 4      R 6      R 3      R 4      R 6       R 4       R
  Ceftriaxone 1      I 0.5   S 0.75 S 0.38 S 0.75  S 0.75  S
  TMP/SMXm ³32  R ³32  R ³32  R ³32  R ³32   R ³32   R
  Erythromycin 0.25 S 0.25 S 16    R 16    R 0.25  S 0.25  S
  Serotype 14 14 9V 9V 9V 9V
  PFGE patternn AA AA BB BB BC BC
aMyocardial infarction.
bCoronary artery disease.
cChronic obstructive pulmonary disease.





iFor sputum or ETT aspirates, 3+ & 4+ reflect growth on the third and fourth set of streaks, respectively, on the culture plate; for BAL, sample
fluid is an approximately 100-fold dilution of lung fluid.
jGram-positive lancet-shaped cocci found singly, in pairs or in short chains.
kGram-negative coccobacilli.
lAntibiotic susceptibilities reported as MIC (micrograms/mL) and as S (susceptible), I (intermediate) or R (resistant) (NCCLS criteria).
mTMP/SMX (trimethoprim/sulfamethoxazole).
nPulsed-field gel electrophoresis.156 Emerging Infectious Diseases Vol. 5, No. 1, JanuaryFebruary 1999
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Couple B (who could not be reached for
further information) had had recent visitors
from Texas (one a hospital worker) with upper
respiratory tract infections. S. pneumoniae
pneumonia was presumptively diagnosed in this
couple on the basis of symptoms, signs, and chest
X-rays compatible with the diagnosis of
pneumonia, as well as sputum samples, which
had gram-positive lancet-shaped cocci identified
on Gram stain and grew S. pneumoniae. From
the sputum of patient 2 in couple B, gram-
negative bacilli were identified on Gram stain;
Haemophilus influenzae was also isolated. Thus,
this patient may have been coinfected, or
primarily infected, with H. influenzae. The
patients blood cultures were negative; a blood
culture was not performed on patient 1 in couple B.
Couple C was admitted with severe burns
and inhalation injuries after the stove in their
two-room trailer exploded. They had had
recurrent sinusitis and other respiratory
infections in the previous year since moving to
their trailer, which had poor air circulation.
Patient 1 of this couple was taking antibiotics at
the time of admission, and patient 2 had recently
completed a course of antibiotics. The diagnosis
of pneumonia (patient 1 on day 3 of admission
and patient 2 on day 2) was made on the basis of
recent upper respiratory symptoms and fever,
diminished breath sounds, crepitations, and
disease-compatible chest X-ray findings (previ-
ous films had been normal), which made
pneumonia more likely than noninfectious
conditions such as acute lung syndrome. The
presumptive diagnosis of S. pneumoniae as the
etiologic agent in the case of patient 1, couple C,
was made on the basis of the initial endotracheal
tube aspirate, which had gram-positive lancet-
shaped cocci identified on Gram stain and grew
S. pneumoniae. Only gram-positive lancet-
shaped cocci were identified from the initial
bronchoalveolar lavage of patient 2 on Gram
stain, and S. pneumoniae grew in much greater
numbers than H. influenzae. Blood cultures,
performed for couple C only after antibiotic
therapy was started, were negative. Patient 2
died of septic shock 20 days after admission, with
Candida albicans in his blood. The bronchop-
neumonia never resolved clinically, although
S. pneumoniae was not isolated from any further
cultures. Thus, S. pneumoniae may have been a
contributing factor to, but not likely the direct
cause, of this patients death.
The identical susceptibility patterns, sero-
types, and PFGE patterns indicate that both
partners in each couple were infected with the
same multidrug-resistant S. pneumoniae strain.
Couples A and B apparently had community-
acquired pneumonia. Although couple C con-
tracted pneumonia 48 to 72 hours after
admission, each partner entered the hospital
already infected with MDRSP; the infecting
organisms were identical, and no other
recognized cases of nosocomial MDRSP occurred
at Foothills Medical Centre at the time of their
admission (they were admitted 1 month before
couple B, who were also infected with serotype
9V MDRSP). Couple A may have been exposed to
MDRSP as a result of one partners work in a
tertiary-care hospital; couple B as a result of one
partners exposure to a health-care worker with
respiratory symptoms. At the time of these cases,
the prevalence of penicillin-nonsusceptible
S. pneumoniae infections in Calgary was
approximately 10% (A.P. Gibb, unpub. data).
None of these patients had received
S. pneumoniae vaccine, yet each had one or more
risk factors for infection (advanced age, exposure
to young children, smoking, and chronic lung or
heart disease). Couple C had a history of recent
antibiotic use, the predominant risk factor for
antibiotic-resistant infections.
In Canada, the S. pneumoniae vaccine is
recommended for all persons ³65 years old and
persons ³2 years with identified risk factors (14).
Despite the vaccines reasonable effectiveness,
its use has been very low in Canada until
recently (fewer than 12 doses per 10,000
population distributed annually [15,16]). The
vaccine has been provided free of charge to
persons with medical indications, but not to
healthy persons 65 years of age and older and not
as part of a routine vaccination schedule (17).
Some provinces (including Alberta, beginning in
1998) have begun to routinely provide the
vaccine to all persons at risk. The current
incidence of invasive S. pneumoniae infections in
Calgary is 20 per 100,000 per year overall and 87
per 100,000 per year in those older than 64 years
of age (J.D. Klein, unpub. data).
Outbreaks of S. pneumoniae disease occur in
institutions with crowding, poor air quality, or
increased host susceptibility (2,4,6). These
factors may also exist within households (9,11).
Couple C, for example, lived in a very crowded
space with poor air circulation.157 Vol. 5, No. 1, JanuaryFebruary 1999 Emerging Infectious Diseases
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The rate at which secondary S. pneumoniae
infections occur in household contacts of index
patients with invasive disease is not known, but
rare cases have been reported (7-11). Factors
contributing to secondary infections include the
likelihood of nasopharyngeal infection due to
exposure to the index patient or a common
source, susceptibility to the strain of the index
infection, and likelihood that colonization will
lead to disease rather than to development of
asymptomatic immunity. Data on contempora-
neous nasopharyngeal carriage of the outbreak
strain by household contacts are limited. A
recent study from Gambia found carriage in 8.5%
of household contacts, compared with 21% in an
older U.S. study (18,19). In healthy adults, the
prevalence of circulating S. pneumoniae antibod-
ies is low (4% to 34%, depending on the serotype);
however, two thirds of adults have protective
antibody within 1 month of colonization (20).
Approximately 15% of children who acquire a
new  S. pneumoniae strain nasopharyngeally in a
nonoutbreak setting acquire clinical disease
(usually otitis media); this rate is unknown for
adults (21). In contrast, during a recent nursing-
home pneumonia outbreak, 23% of residents
were infected with the S. pneumoniae outbreak
strain, and 4% became ill (22). The median age of
residents was 85 years; only 4% had received
S. pneumoniae vaccine.
Increased use of S. pneumoniae vaccine
may prevent MDRSP pneumonia within
households and among persons living in
crowded conditions.
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